BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Monday, May 6, 2024
See today's BioWorld
Home
» Other news to note for Nov. 10, 2021
X
Upgrade your daily dose of biopharma and medtech news
Subscribe to BioWorld™ news services
See subscription options
To read the full article
sign up for free
or
sign in
.
Other news to note for Nov. 10, 2021
Nov. 10, 2021
No Comments
Biopharma happenings, including deals and partnerships, grants, preclinical data and other news in brief: 4E, Abbvie, Acorda, Autolus, Avrobio, Bioinvent, BMS, Chemomab, Creative Manufacturing, Dynacure, Eli Lilly, Esteve, Erytech, Evgen, Evotec, Exavir, Geovax, Ginkgo, Gritstone, Hepion, Hyloris, ICER, I-Mab, Jasper, Jumpcan, Kronos, Lennham, Ligand, Mannkind, Merck, Monte Rosa, Mustang, Nippon Shinyaku, Ridgeback, Strand, Surface, Transgene, Ziopharm.
BioWorld
Briefs
Other news to note
Coronavirus